Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Perlis

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Prostate International|July 1, 2026
Irreversible electroporation in focal therapy for prostate cancer: current status and future directionsFrancisco O Durazo-Ruiz, Rocío Roldán-Testillano, Lara Rodriguez-Sanchez, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Plos One|September 8, 2023
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysisSeraphine Zeitouny, Douglas C Cheung, Karen E Bremner, et al.
The Journal of Urology|April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA TrialAlon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
The Journal of Urology|July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: ErratumAlon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered TrialHari T Vigneswaran, Martin Eklund, Andrea Discacciati, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
CMAJ Open|September 20, 2022
Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort studyTeresa C O Tsui, Seraphine Zeitouny, Karen E Bremner, et al.
BJU International|May 26, 2025
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression riskJethro C C Kwong, Keiran Pace, Zizo Al-Daqqaq, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Prostate International|July 1, 2026
Irreversible electroporation in focal therapy for prostate cancer: current status and future directionsFrancisco O Durazo-Ruiz, Rocío Roldán-Testillano, Lara Rodriguez-Sanchez, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Plos One|September 8, 2023
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysisSeraphine Zeitouny, Douglas C Cheung, Karen E Bremner, et al.
The Journal of Urology|April 9, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA TrialAlon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
The Journal of Urology|July 8, 2025
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: ErratumAlon Lazarovich, Hari Vigneswaran, Thorgerdur Palsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered TrialHari T Vigneswaran, Martin Eklund, Andrea Discacciati, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
CMAJ Open|September 20, 2022
Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort studyTeresa C O Tsui, Seraphine Zeitouny, Karen E Bremner, et al.
BJU International|May 26, 2025
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression riskJethro C C Kwong, Keiran Pace, Zizo Al-Daqqaq, et al.
Pageof 11